RADIOTRON™
Bringing precision medicineto radiotherapy
Radiotherapy is an important modality in treating cancer patients. Radiotron™ is a 511-gene panel for all solid tumors that is upgraded from GeneseeqPrime™ 437-gene panel. It has a total of 118 genes associated with radiosensitivity, radiotherapy tolerance and susceptibility to radiation-induced second cancer.
WHO IS IT FOR
Solid tumor patients seeking personalized drug and radiotherapy
SAMPLE TYPES
Tumor tissue (FFPE block/slides, or frozen tissue)
Fine needle biopsy
LET’S ACCELERATE PRECISION CANCER CARE, TOGETHER.
Learn more about our products and services or contact us today to discuss how we can partner together.
